CHTN VUMC, Canada
Registration Status: Pending
Objective: VUMC-CHTN is primarily funded by the National Cancer Institute as a human surgical and autopsy remnant tissue procurement facility. Federal funds support less than 25% of operational costs with the other 75% of costs being recouped via services. The biorepository operates under a waiver of consent and also consents participants for use of remnant tissue and biofluid collection. Academic and commercial investigators with R&D protocols are encouraged to apply. We are not subsidized to support clinical trials.
Registered Biobank Name | CHTN VUMC |
Biobank Leader | Kerry Wiles |
Country | Canada |
Email for biobank inquiries | kerry.wiles@vumc.org |
Principal Investigator | Dr. Mary Kay Washington |
Website | |
User Type
|